Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
27.75
-0.37 (-1.32%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Dianthus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21
Market Capitalization
815154--
Enterprise Value
455-35--
Last Close Price
27.7510.40--
PE Ratio
--1.23--
PS Ratio
138.9154.53--
PB Ratio
2.270.91--
P/FCF Ratio
-14.77-4.17--
P/OCF Ratio
-14.80-4.18--
EV/Sales Ratio
110.40-12.42--
EV/EBITDA Ratio
-5.580.73--
EV/EBIT Ratio
-5.570.73--
EV/FCF Ratio
-7.450.95--
Debt / Equity Ratio
0.000.000.01-
Debt / FCF Ratio
-0.01-0.02-0.03-
Asset Turnover
0.020.020.14-
Quick Ratio
36.1318.099.861.70
Current Ratio
36.4618.429.971.75
Return on Equity (ROE)
-27.33%-35.92%-73.25%-
Return on Assets (ROA)
-19.84%-22.94%-40.12%-
Return on Capital (ROIC)
-20.67%-24.69%-47.27%-
Earnings Yield
-6.96%-28.26%--
FCF Yield
-6.31%-23.99%--
Buyback Yield / Dilution
-413.54%-489.48%78.18%-
Total Shareholder Return
-413.54%-489.48%78.18%-
Source: S&P Capital IQ. Standard template. Financial Sources.